| Ab | Antibodies |
| Ag | Antigen |
| CI | Confidence interval |
| COR-NTD | Coalition for Operational Reseach on Neglected Tropical Diseases |
| COVID-19 | Coronavirus-19 |
| ENGAGE | Ending the Neglect through Greater Access and Greater Effectiveness |
| GAELF | Global Alliance to Eliminate Lymphatic Filariasis |
| HERA | Health Research Accelerator (program of The University of Queensland) |
| NHMRC | National Health and Medical Research Council |
| NTD | Neglected-tropical disease |
| LF | Lymphatic filariasis |
| M&E | Monitoring and evaluation |
| MBA | Mulitplex bead assay |
| Mf | Microfilaria |
| NCD | Non-communicable disease |
| PacELF | Pacific Programme to Eliminate Lymphatic Filariasis |
| PICTs | Pacific Island Countries and Territories |
| PVS | Post-validation surveillance |
| SERO-PAC | Serosurveillance Partnership for the Pacific Region |
| STEPs and STEPwise | “STEPs” and “STEPwise” refer to the step-by-step structure of the WHO NCD risk factor survey methodology rather than being an acronym |
| UQ | The University of Queensland |
| WHO | World Health Organization |